All News

Budesonide/glycopyrrolate/formoterol fumarate (Breztri Aerosphere, AstraZeneca) has been approved by the FDA for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD), according to a press release.

The latest update from the CDC incorporates evidence that informs the duration of isolation and precautions recommended to prevent transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to others while limiting unnecessary prolonged isolation and unnecessary use of laboratory testing resources.

Spinal muscular atrophy is the leading genetic cause of death in infants.

Overtreatment of acute cough can help reduce antibiotic use.

Earlier results of the FAST trial, which was launched in 2004, found that reducing the number of radiotherapy fractions to 5 was feasible and safe in the short term.

Time for Care, a campaign reinforcing the importance of accessing primary health care, has been launched by CVS Health to remind Americans of the importance of prioritizing their health during the coronavirus disease 2019 (COVID-19) pandemic, according to the company.

Which former US Vice President was also a pharmacist?

Top news of the week from Pharmacy Times®.

The new findings suggest that screening and proper management of prediabetes may help to prevent CVD in otherwise healthy individuals, or primary prevention, as well as those with existing heart problems, or secondary prevention, according to the study.

An increasing amount of evidence points to the possibility of COVID-19 causing cardiovascular-neurological dysfunction.

Long-term care (LTC) pharmacies caring for this population face a myriad of unique obstacles, especially the regulatory framework surrounding them.

Angiotensin peptides are short proteins that regulate the cardiovascular system and are altered in patients with heart failure and those with COVID-19, according to the press release.

Consumers and providers were asked for their thoughts on the state of health care and how they are navigating this evolving landscape during the coronavirus 2019 (COVID-19) pandemic.

Favipiravir is not approved by the FDA. It is being researched in the United States as a potential treatment of COVID-19.

Data show that immunotherapy doesn’t necessarily worsen complications for patients with both COVID-19 and cancer.

Poor cardiorespiratory fitness can lead to premature death and high blood pressure.

Both REM and non-REM sleep contribute to visual learning and overall brain health.

The review also summarized proposed mechanisms behind these wide-ranging systemic effects and provided clinical guidance for physicians, according to a press release.

The test is intended to determine whether someone is currently infected with COVID-19 and if they have been infected in the past.

Without an FDA approved treatment or vaccine for COVID-19, masks are the best form of protection, according to the CDC.

Steven C. Anderson, FASAE, CAE, IOM, president and CEO of the National Association of Chain Drug Stores, has been invited to join the office of Health and Human Services’ new COVID-19 Vaccine Consultation Panel.

Status reaffirms PTCE as the leader in continuing pharmacy education

The combination medication is used to treat the symptoms of tension or muscle contraction headaches. The drug is only available via a prescription from a physician.

In addition to its potential uses in cancer treatment, this novel drug delivery system could be used with magnetic resonance imaging or fluorescence imaging.